Tak-220
Title | Journal |
---|---|
Design, synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperazine derivatives as CCR5 antagonist-based HIV-1 entry inhibitors. | Bioorganic & medicinal chemistry letters 20120501 |
Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists. | Molecular pharmacology 20080301 |
Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652. | Antimicrobial agents and chemotherapy 20070201 |
Discovery of a piperidine-4-carboxamide CCR5 antagonist (TAK-220) with highly potent Anti-HIV-1 activity. | Journal of medicinal chemistry 20060504 |
Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist. | Antimicrobial agents and chemotherapy 20050801 |